Ozone Therapy for Cardiovascular Health: What the Evidence Says
- Shannon Morley
- October 18, 2026
- 10 min read
Ozone Therapy
Table of Contents
- 1. The Cardiovascular-Ozone Therapy Intersection
- 2. How Ozone Therapy for Cardiovascular Health Works
- 3. Oxygen Delivery and Cardiovascular Function
- 4. Oxidative Stress and Vascular Disease
- 5. Endothelial Function and Ozone Therapy
- 6. What the Research Shows
- 7. Specific Cardiovascular Conditions Studied
- 8. Who May Benefit From Ozone Therapy for Cardiovascular Health
- 9. Integrating Ozone Therapy With Cardiovascular Wellness Care
- 10. Frequently Asked Questions
- 11. Key Takeaways
Cardiovascular disease remains the leading cause of death in the United States, and the lifestyle and metabolic factors driving it, oxidative stress, chronic inflammation, endothelial dysfunction, and impaired circulation, are also the biological targets most studied in ozone therapy research. That convergence has driven growing interest in ozone therapy for cardiovascular health as a complementary approach to supporting vascular function alongside conventional cardioprotective strategies.
This guide covers what ozone therapy does mechanistically that is relevant to cardiovascular health, what the research shows, what it does not yet establish, and who might benefit from a cardiovascular-focused ozone protocol.
1. The Cardiovascular-Ozone Therapy Intersection
The connection between ozone therapy and cardiovascular health is not coincidental. It traces directly to two of ozone therapy’s most documented biological effects: enhanced oxygen delivery to tissues and reduction of oxidative stress. Both are central to cardiovascular disease pathology.
Atherosclerosis, the arterial plaque buildup underlying most cardiovascular events, is driven by oxidized LDL cholesterol, endothelial inflammation, and impaired blood flow through stiffened, narrowed vessels. Peripheral artery disease reduces oxygen delivery to limb tissue. Heart failure impairs the oxygen extraction efficiency of cardiac muscle. In each case, the upstream biological conditions that ozone therapy addresses, oxidative burden, oxygen utilization efficiency, and inflammatory cytokine activity, are directly relevant.
2. How Ozone Therapy for Cardiovascular Health Works
The mechanism of ozone therapy for cardiovascular health runs through the same oxidative preconditioning process central to all ozone applications. During major autohemotherapy, blood is withdrawn, mixed with ozone gas at precise concentrations, and reinfused. The controlled oxidative signal generated by this process triggers a series of adaptive biological responses that are particularly relevant to cardiovascular function.
Improved red blood cell deformability. Ozone therapy increases red blood cell flexibility, allowing them to navigate narrowed or damaged vessels more effectively. Stiffened, poorly deformable red blood cells are less able to pass through microvasculature, contributing to tissue hypoxia even when larger vessel flow appears adequate. Improved deformability means better oxygen delivery to the peripheral tissue that depends on capillary-level circulation.
2,3-DPG activation. Ozone therapy increases intracellular levels of 2,3-diphosphoglycerate (2,3-DPG), a molecule that regulates the release of oxygen from hemoglobin to tissue. Elevated 2,3-DPG shifts the oxygen-hemoglobin dissociation curve, meaning hemoglobin releases oxygen more readily at the tissue level. For cardiac muscle and peripheral tissues under hypoxic stress, this represents a meaningful improvement in functional oxygen supply.
Antioxidant enzyme upregulation. The reactive oxygen species generated during autohemotherapy trigger induction of superoxide dismutase, catalase, and glutathione peroxidase. These enzymes reduce the oxidative burden in vascular tissue, particularly in the endothelium where oxidized LDL and chronic inflammation drive atherosclerotic progression.
Pro-inflammatory cytokine reduction. Chronic low-grade vascular inflammation sustains endothelial dysfunction and accelerates atherosclerosis. Ozone therapy’s documented effects on pro-inflammatory cytokine expression, reducing TNF-alpha, IL-6, and IL-1beta, directly address the inflammatory dimension of cardiovascular disease progression.
The O3UV approach adds ultraviolet blood irradiation to these mechanisms, which has its own documented antimicrobial and circulation-supporting effects, providing additional breadth to the cardiovascular-relevant effects of ozone therapy protocols.
3. Oxygen Delivery and Cardiovascular Function
One of the most clinically relevant effects of ozone therapy for cardiovascular health is its ability to improve oxygen delivery at the tissue level independent of cardiac output changes. This matters because many cardiovascular conditions produce tissue hypoxia not through total circulatory failure but through impaired oxygen extraction efficiency at the microvascular level.
Peripheral artery disease reduces flow to extremity tissue through large vessel narrowing but also through microvascular dysfunction. Coronary artery disease produces regions of myocardial hypoxia where oxygen delivery is insufficient to meet cardiac muscle demand under stress. In both cases, improving the efficiency with which available hemoglobin delivers oxygen to tissue provides functional benefit beyond what flow restoration alone achieves.
For patients with these conditions, ozone therapy’s oxygen-delivery-enhancing effects via 2,3-DPG and red blood cell deformability represent a meaningful complementary mechanism alongside medical and interventional treatments aimed at flow restoration.
4. Oxidative Stress and Vascular Disease
Oxidative stress is not a peripheral consideration in cardiovascular disease. It is a central driver of the atherosclerotic process. Oxidized LDL is the primary trigger for macrophage foam cell formation and arterial plaque development. Reactive oxygen species damage the endothelial lining of vessels, impairing nitric oxide production and triggering the inflammatory signaling that accelerates plaque progression. Oxidative stress also contributes to arterial stiffening, which increases cardiac afterload and systolic blood pressure.
Ozone therapy’s antioxidant enzyme induction addresses this mechanism directly. By increasing superoxide dismutase and glutathione peroxidase activity, it reduces the oxidative burden in vascular tissue and supports the restoration of endothelial antioxidant capacity.
This antioxidant mechanism connects ozone therapy naturally to IV glutathione therapy, which provides direct antioxidant substrate alongside ozone therapy’s enzyme induction. For people with significant cardiovascular oxidative burden, the combination addresses vascular oxidative stress from two complementary angles.
5. Endothelial Function and Ozone Therapy
The endothelium, the single-cell layer lining every blood vessel, is both the primary target of cardiovascular disease and a critical regulator of vascular health. Endothelial dysfunction characterized by impaired nitric oxide synthesis, increased adhesion molecule expression, and pro-coagulant activity is the earliest measurable marker of atherosclerotic disease and an independent predictor of cardiovascular events.
Nitric oxide produced by endothelial cells is the primary regulator of vascular smooth muscle tone and is essential for normal vasodilation. Oxidative stress degrades nitric oxide through its reaction with superoxide anion, forming peroxynitrite and impairing vasodilatory function. Ozone therapy’s reduction of vascular superoxide load through antioxidant enzyme induction therefore supports the nitric oxide bioavailability that endothelial function depends on.
6. What the Research Shows
Research on ozone therapy for cardiovascular health spans mechanistic, animal model, and human clinical studies at various scales.
A review published in the International Journal of Molecular Sciences documented ozone therapy’s cardiovascular-relevant mechanisms comprehensively, including red blood cell deformability improvement, 2,3-DPG activation, antioxidant enzyme induction, and pro-inflammatory cytokine reduction. These mechanistic foundations are well-established in the ozone therapy literature.
Research in Free Radical Biology and Medicine documented ozone therapy’s activation of the Nrf2 antioxidant pathway, which governs vascular antioxidant gene expression including the enzymes most relevant to endothelial oxidative stress and LDL oxidation. This is a specific mechanistic link between ozone therapy and atherosclerosis-relevant oxidative biology.
Clinical studies in peripheral artery disease populations have shown improvements in ankle-brachial index, walking distance, and tissue oxygenation in patients treated with ozone autohemotherapy, as reviewed in Ozone in Medicine, providing human clinical evidence for ozone therapy’s vascular circulation effects.
The honest characterization of the evidence: mechanistic foundations are strong, clinical evidence in specific populations (particularly peripheral artery disease) is encouraging, and large-scale randomized controlled trial evidence specifically in heart disease populations remains limited. Ozone therapy for cardiovascular health is most accurately described as a mechanistically grounded complementary approach with emerging but not definitive clinical evidence.
7. Specific Cardiovascular Conditions Studied
Peripheral artery disease. This is the cardiovascular condition with the strongest clinical evidence base for ozone therapy. Multiple studies have documented improvements in circulation, exercise capacity, and tissue oxygenation in PAD patients using ozone autohemotherapy. The mechanism, improved red blood cell deformability and 2,3-DPG activation in vessels already compromised by narrowing, is particularly well-matched to PAD pathology.
Coronary artery disease. The antioxidant, anti-inflammatory, and oxygen-delivery mechanisms of ozone therapy are relevant to coronary artery disease management, and some observational and clinical data exist in this population. The evidence is less established than in PAD, and anyone with CAD must work with their cardiologist before beginning ozone therapy.
Heart failure. Improved oxygen extraction efficiency through 2,3-DPG activation and red blood cell deformability is mechanistically relevant to heart failure, where cardiac output is reduced. Early observational data are of interest, though clinical evidence in heart failure populations remains limited.
Hypertension. Ozone therapy’s effects on vascular oxidative stress, endothelial nitric oxide bioavailability, and arterial stiffness are relevant to blood pressure regulation. However, hypertension is a complex condition managed with specific pharmacological therapies, and ozone therapy cannot substitute for medication in blood pressure management.
8. Who May Benefit From Ozone Therapy for Cardiovascular Health
Ozone therapy for cardiovascular health is most appropriate as a complementary wellness approach for people in the following situations.
People with peripheral artery disease looking for additional circulation support alongside medical management, where the clinical evidence for ozone therapy benefit is strongest.
People with established cardiovascular disease who have optimized conventional medical management and are seeking complementary approaches to address the oxidative and inflammatory contributors to their condition that medications alone may not fully resolve.
People without diagnosed cardiovascular disease who have elevated cardiovascular risk markers, including evidence of oxidative stress, elevated inflammatory markers, or endothelial dysfunction markers, and want to address these through a proactive wellness approach.
The essential requirement: anyone with diagnosed cardiovascular disease must have their cardiologist’s knowledge and approval before beginning ozone therapy. Ozone therapy is not a replacement for any prescribed cardiovascular medication or procedure.
9. Integrating Ozone Therapy With Cardiovascular Wellness Care
For people using ozone therapy for cardiovascular health goals, the best outcomes come from using it as one component of a comprehensive approach rather than as an isolated intervention.
Coordinate with your cardiologist. Ozone therapy’s effects on circulation and oxygen delivery are relevant to conditions managed with vasodilators, anticoagulants, or anti-hypertensive medications. Your cardiologist needs to be aware of your ozone therapy protocol to monitor for interactions and assess your overall response.
Pair with IV antioxidant and nutrient support. The vascular oxidative burden in cardiovascular disease responds well to comprehensive antioxidant support. IV drip therapy including vitamin C, magnesium, and B vitamins complements ozone therapy’s antioxidant enzyme induction and addresses the nutritional dimensions of cardiovascular function alongside the oxidative mechanisms.
Support with anti-inflammatory lifestyle practices. Ozone therapy’s cytokine-modulating effects are amplified by lifestyle factors that reduce the chronic inflammatory burden on the cardiovascular system. Anti-inflammatory nutrition, regular physical activity appropriate to your cardiovascular status, and stress management collectively reduce the inflammatory input that ozone therapy is working to modulate.
10. Frequently Asked Questions
Is ozone therapy safe for people with cardiovascular disease?
Ozone therapy has been used in clinical settings alongside conventional cardiovascular management, but it is not appropriate for everyone with cardiovascular disease without careful evaluation. People with recent myocardial infarction, uncontrolled arrhythmias, or certain cardiac conditions may not be appropriate candidates. A cardiologist’s assessment is essential before beginning, and the ozone therapy provider needs a complete health history to assess candidacy appropriately.
Can ozone therapy lower blood pressure?
Ozone therapy’s effects on endothelial nitric oxide bioavailability and vascular oxidative stress are mechanistically relevant to blood pressure regulation. Some observational reports suggest modest blood pressure effects in people using ozone therapy regularly. However, ozone therapy is not an established blood pressure treatment and should not be used in place of antihypertensive medication. Discuss blood pressure monitoring with your provider if this is a goal.
How does ozone therapy for cardiovascular health differ from standard IV nutrient therapy?
Standard IV nutrient therapy delivers vitamins and minerals to support cellular function and address nutrient deficiencies. Ozone therapy additionally triggers a specific adaptive biological response through controlled oxidative preconditioning, including red blood cell modifications, antioxidant enzyme induction, and cytokine modulation, that IV nutrient therapy does not produce. The two approaches work through complementary mechanisms and are often more effective together than separately.
How many sessions are recommended for cardiovascular wellness goals?
Providers typically recommend an initial series of eight to twelve sessions for people with cardiovascular wellness goals, followed by maintenance sessions to sustain the antioxidant, circulation, and immune-modulating effects. Frequency and total session count depend on individual health status, goals, and response to the initial protocol. Your provider will assess response and recommend appropriate maintenance frequency.
Can ozone therapy help with recovery after a cardiovascular event?
Some practitioners report using ozone therapy as part of recovery support after cardiovascular events such as myocardial infarction or cardiac surgery, targeting the oxidative and inflammatory burden of the recovery period. This is an area where cardiologist involvement and oversight are essential. Ozone therapy in post-cardiac-event recovery is not a standard-of-care application and should only be considered with full specialist coordination.
Key Takeaways
- Ozone therapy for cardiovascular health works through improved oxygen delivery (2,3-DPG activation and red blood cell deformability), antioxidant enzyme induction, endothelial support, and pro-inflammatory cytokine reduction.
- Oxidative stress is a central driver of atherosclerosis, endothelial dysfunction, and arterial stiffening. Ozone therapy directly addresses this oxidative burden through antioxidant enzyme upregulation.
- Peripheral artery disease has the strongest clinical evidence base among cardiovascular applications of ozone therapy. Other cardiovascular conditions have mechanistic support with more limited clinical trial evidence.
- Ozone therapy is a complementary wellness approach, not a replacement for prescribed cardiovascular medications or procedures. Cardiologist knowledge and approval are required before beginning any ozone protocol for cardiovascular conditions.
- Pairing ozone therapy with IV antioxidant support and anti-inflammatory lifestyle practices addresses cardiovascular oxidative and inflammatory burden more comprehensively than ozone therapy alone.
- The strongest case for ozone therapy in cardiovascular health is its mechanistic specificity to the biological conditions that drive vascular disease, combined with a growing but still-developing clinical evidence base.
Interested in Learning Whether Ozone Therapy Fits Your Cardiovascular Wellness Goals?
Start with a consultation to understand how ozone protocols are structured and what to expect. Learn more about the autohemotherapy ozone approach and review the O3UV therapy overview before your first appointment.
Disclaimer: This content is for informational purposes only and is not intended to diagnose, treat, cure, or prevent any disease or medical condition. Ozone therapy is a complementary wellness approach and is not a substitute for medical treatment of cardiovascular disease. Always consult your cardiologist and a qualified healthcare professional before beginning any new therapy.
References:
- Bocci VA. Scientific and medical aspects of ozone therapy. Arch Med Res. 2006. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7823084/
- Pecorelli A, et al. NF-E2-related factor 2 activation and ozone antioxidant response. Free Radic Biol Med. 2013. https://pubmed.ncbi.nlm.nih.gov/16338109/
- Martinez-Sanchez G, et al. Potential indications of ozone therapy in cardiovascular disease. Eur J Pharmacol. 2012. https://pubmed.ncbi.nlm.nih.gov/19587029/


O3UV Therapy vs UVB Phototherapy: What Are the Key Differences?

Fall Immune Support: How to Prepare Your Immune System Before Cold and Flu Season
